Diffuse large B-cell lymphoma primary of lung

Hematology

Volumn 16, Issue 2, 2011, Pages 110-112

  Neri, Natividad ^a   Nambo, M Jesús ^a   Avilés, Agustin ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Immunohistochemistry; Lung lymphoma; Malignant lymphoma; Prognostic factors

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CARDIOTOXICITY; CONTROLLED STUDY; COUGHING; DRUG FATALITY; DRUG TOLERABILITY; EVENT FREE SURVIVAL; FEMALE; GERMINAL CENTER; GRANULOCYTOPENIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHENOTYPE; PNEUMONIA; PRIMARY LUNG LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; THORAX PAIN; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 79952643160     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453311X12940641877722     Document Type: Article

References (17)

1. Cadranel J, Wiscez M, Antoine M. Primary pulmonary lymphoma. Eur Resp J 2002;20:750-762.
2. Cordier JF, Chailleux E, Lauque J, Reynaud-Gaubert M, Dietemann-Molard A, Dalphin JC, et al. Primary pulmonar lymphomas. A clinical study of 70 cases in non-immunocompromised patients. Chest 1993;103:210-8
3. Li G, Hansman ML, Zwinterns T, Lennert K. Primary lung lymphoma. Histopathology 1990;16:519-21.
4. Graham GB, Mathissen DJ, Mark EJ, Takvorian RW. Primary pulmonary lymphoma. Ann Thorac Surg 2005;80:1248-53. (Pubitemid 41354097)
5. Ferraro P, Trastek VF, Adlakha H, Deschamps C, Allen MS, Pairolero PC. Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg 2000;69:993-7 (Pubitemid 30259436)
6. Chilosi M, Zinzani PL, Poletti U. Lymphoproliferative lung disorders. Sem Resp Crit Med 2005;26:490-502.
7. de Jong D, Rosenwald A, Chlanabhai M, Gaulard P, Klapper W, Lee A, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma. J Clin Oncol 2007;25:805-12.
8. Greissner B, Küppers R, Siebert R, Glass B, Trümper L, Hiddemann W, et al. Report of a workshop on malignant lymphoma. A review of molecular and clinical risk profile. Br J Haematol 2008;142:166-178. (Pubitemid 351994054)
9. Yoshida S, Nakamura S, Sasaki Y, Yoshida S, Yasuda M, Sagara H, et al. Primary breast lymphoma shows an nongerminal B-centre phenotype. Mod Pathol 2005;18:398-405. (Pubitemid 40395359)
10. Al-Abbadi MA, Hatta EM, Tarwerer M, Orazi A, Ulbright IM. Primary testicular diffuse large B-cell lymphoma belongs of the germinal B-cell like subgroup. Mod Pathol 2006;19:1521-27. (Pubitemid 44789919)
11. Lin CH, Kuo KT, Chuang SS, Kuo SH, Chang JH, Chang KC, et al. Comparison of the expression of prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system and peripheral nodal origin. Clin Cancer Res 2006;12:1152-6 (Pubitemid 43342503)
12. Mitchel KA, Finn WG, Owens SR. Differences in germinal center and non-germinal center phenotype in gastric and intestinal diffuse large B-cell lymphoma. Leuk Lymphoma 2008;49:1717-23.
13. Heyning FH, Hogendoorn PC, Kramer MH, Holland CT, Dreef E, Jansen PM. Primary lymphoma of bone: extranodal lymphoma with favorable prognosis independent of germinal centre, post-germinal centre or indeterminate phenotype. J Clin Pathol 2009;62:820-4
14. Sato Y, Nanko U, Morito T, Takata K, Mizobuchi K, Nagatsuka H, et al. Patients with localized primary nontonsilar oral diffuse large B-cell lymphoma exhibit favorable prognosis despite non-germinal center B-cell-like phenotype. Cancer Sci 2009;100:42-6.
15. Ilic I, Mitrovic Z, Aurere I, Basić-Kinda S, Radman I, Ajduković R, et al. Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab. Int J Haematol 2009;90:74-80.
16. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an International Workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 1999;17:244-53.
17. Hans CD, Weisenburguer DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a microarray tissue. Blood 2004;103:275-82. (Pubitemid 38029949)